Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A sarcoidosis that involves the nervous system.
Biomarker and diagnostic research for neurosarcoidosis has been reported in the published literature.
No clinical trials have been registered for neurosarcoidosis.
232 publications have been identified in PubMed for neurosarcoidosis. Research spans Case Report / Case Series (54%), Review / Meta-Analysis (19%), and Diagnostic / Biomarker (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 125 | 54% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 4:09 AM UTC
43 |
19% |
Testing and diagnosis research | 21 | 9% |
Clinical study results | 16 | 7% |
Disease patterns and progression | 14 | 6% |
Other research | 8 | 3% |
Laboratory research | 3 | 1% |
New treatment approaches | 2 | 1% |
Oliveira N (2026). [PMID: 41694903](https://pubmed.ncbi.nlm.nih.gov/41694903/). *Cureus*. [Case Report / Case Series]
Rommer PS (2026). [PMID: 41671531](https://pubmed.ncbi.nlm.nih.gov/41671531/). *Neurology(R) neuroimmunology & neuroinflammation*. [Case Report / Case Series]
Miedema J (2026). [PMID: 41651390](https://pubmed.ncbi.nlm.nih.gov/41651390/). *Autoimmun Rev*. [Review / Meta-Analysis]
Zarrouk S (2026). [PMID: 40866270](https://pubmed.ncbi.nlm.nih.gov/40866270/). *Intern Med*. [Case Report / Case Series]
Carneiro G (2026). [PMID: 41804449](https://pubmed.ncbi.nlm.nih.gov/41804449/). *Cureus*. [Case Report / Case Series]
Hutto SK (2026). [PMID: 42127566](https://pubmed.ncbi.nlm.nih.gov/42127566/). *J Neurol Sci*. [Other]
Murillo DJS (2026). [PMID: 42190341](https://pubmed.ncbi.nlm.nih.gov/42190341/). *J Neuroimmunol*. [Diagnostic / Biomarker]
Karaman N (2026). [PMID: 42008836](https://pubmed.ncbi.nlm.nih.gov/42008836/). *J Neurosurg Case Lessons*. [Diagnostic / Biomarker]
Sun Q (2026). [PMID: 41695168](https://pubmed.ncbi.nlm.nih.gov/41695168/). *Frontiers in medicine*. [Case Report / Case Series]
Maury A (2026). [PMID: 41569740](https://pubmed.ncbi.nlm.nih.gov/41569740/). *Ocul Immunol Inflamm*. [Epidemiology / Natural History]
AI-curated news mentioning neurosarcoidosis
Updated Aug 21, 2026
A case report details systemic sarcoidosis with neurosarcoidosis and obstructive hydrocephalus, highlighting the complex interplay between these conditions. This study contributes to the understanding of radiologic and pathologic features associated with sarcoidosis.
A recent study published in PubMed explores pediatric neurosarcoidosis, highlighting cases with cavernous sinus involvement and internal carotid artery stenosis. This research contributes to the understanding of rare neurological manifestations in children.
A recent study highlights the effectiveness of infliximab in treating tumefactive parenchymal lesions associated with neurosarcoidosis. This research contributes to the understanding of treatment options for this rare manifestation of sarcoidosis.